However, no statistical correlation could be observed between the TYRO3 expression level and survival prognosis in patients having positive neural invasion or negative lymph node metastasis (P > 0.05, Figure 2A). Here, TYRO3 is linked to metastatic malignant neoplasm in the lymph nodes.